Petering H - Search Results

1

The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.

Elsner J, Petering H, Höchstetter R, Kimmig D, Wells TN, Kapp A, Proudfoot AE. Elsner J, et al. Among authors: petering h. Eur J Immunol. 1997 Nov;27(11):2892-8. doi: 10.1002/eji.1830271122. Eur J Immunol. 1997. PMID: 9394815

2

Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils.

Petering H, Höchstetter R, Kimmig D, Smolarski R, Kapp A, Elsner J. Petering H, et al. J Immunol. 1998 Jan 15;160(2):555-8. J Immunol. 1998. PMID: 9551887 Free article.

3

Characterization of the CC chemokine receptor 3 on human keratinocytes.

Petering H, Kluthe C, Dulkys Y, Kiehl P, Ponath PD, Kapp A, Elsner J. Petering H, et al. J Invest Dermatol. 2001 Apr;116(4):549-55. doi: 10.1046/j.1523-1747.2001.01302.x. J Invest Dermatol. 2001. PMID: 11286622 Free article.

4

Characterization of synthetic C3a analog peptides on human eosinophils in comparison to the native complement component C3a.

Petering H, Köhl J, Weyergraf A, Dulkys Y, Kimmig D, Smolarski R, Kapp A, Elsner J. Petering H, et al. J Immunol. 2000 Apr 1;164(7):3783-9. doi: 10.4049/jimmunol.164.7.3783. J Immunol. 2000. PMID: 10725738 Free article.

5

The CC chemokine receptor antagonist met-RANTES inhibits eosinophil effector functions.

Elsner J, Petering H, Kimmig D, Wells TN, Proudfoot AE, Kapp A. Elsner J, et al. Among authors: petering h. Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):462-5. doi: 10.1159/000024164. Int Arch Allergy Immunol. 1999. PMID: 10224475

6

The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils.

Petering H, Götze O, Kimmig D, Smolarski R, Kapp A, Elsner J. Petering H, et al. Blood. 1999 Jan 15;93(2):694-702. Blood. 1999. PMID: 9885232 Free article.

7

Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils.

Elsner J, Petering H, Kluthe C, Kimmig D, Smolarski R, Ponath P, Kapp A. Elsner J, et al. Among authors: petering h. Eur J Immunol. 1998 Jul;28(7):2152-8. doi: 10.1002/(SICI)1521-4141(199807)28:07<2152::AID-IMMU2152>3.0.CO;2-G. Eur J Immunol. 1998. PMID: 9692884 Free article.

8

Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema.

Petering H, Breuer C, Herbst R, Kapp A, Werfel T. Petering H, et al. J Am Acad Dermatol. 2004 Jan;50(1):68-72. doi: 10.1016/s0190-9622(03)00782-5. J Am Acad Dermatol. 2004. PMID: 14699368

9

Ultrarush SIT in venom allergy.

Elsner J, Sack A, Petering H, Schaefer T, Körner M, Kapp A. Elsner J, et al. Among authors: petering h. Allergy. 2000 Jun;55(6):582-3. doi: 10.1034/j.1398-9995.2000.00632.x. Allergy. 2000. PMID: 10858994 No abstract available.

10

[Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].

Petering H, Kiehl P, Vogelbruch M, Sticht-Groh V, Kapp A, Werfel T. Petering H, et al. Hautarzt. 2001 Oct;52(10 Pt 2):966-9. doi: 10.1007/s001050170009. Hautarzt. 2001. PMID: 11715395 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results